2.6611
Connect Biopharma Holdings Ltd Aktie (CNTB) Neueste Nachrichten
What is HC Wainwright's Forecast for CNTB FY2028 Earnings? - MarketBeat
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Reno Gazette Journal
Equities Analysts Offer Predictions for CNTB FY2030 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
3 Promising Penny Stocks With Market Caps Up To $400M - Yahoo Finance
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OPAL Fuels Inc. (NASDAQ:OPAL) Given Average Recommendation of “Reduce” by Analysts - Defense World
NVR, Inc. (NYSE:NVR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Vivos Therapeutics (NASDAQ:VVOS) and Akebia Therapeutics (NASDAQ:AKBA) Head to Head Contrast - Defense World
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7%What's Next? - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7% – What’s Next? - Defense World
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026 - The Manila Times
Connect Biopharma Reports Significant Loss Amid Development Efforts - MSN
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - news-journalonline.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Announces Board Resignation - TradingView — Track All Markets
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks - simplywall.st
Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Connect Biopharma Hldgs (CNTB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22% - Yahoo Finance
Analyzing Connect Biopharma (NASDAQ:CNTB) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives $8.50 Average Price Target from Analysts - Defense World
Connect Biopharma (NASDAQ:CNTB) Now Covered by Analysts at Lake Street Capital - MarketBeat
Check Out Connect Biopharma Holdings Ltd (CNTB)’s Trade Data Rather Than the Analysts’ Views - Setenews
Connect Biopharma (NASDAQ:CNTB) Research Coverage Started at Lake Street Capital - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Lake Street Initiates Coverage on Connect Biopharma (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus
CASI Pharmaceuticals Announces Changes in Board Governance - Investing News Network
Shareholder Panacea Innovation Ltd Files To Sell 2,000,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Taking on analysts’ expectations and winning: Connect Biopharma Holdings Ltd (CNTB) - Setenews
Connect Biopharma Management to Participate in 8th Annual Evercore Healthcare Conference on December 2, 2025 - Quiver Quantitative
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
Shareholder Zheng-Wu Family Trust Files To Sell 650,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Connect Biopharma Holdings Limited (CNTB) -11.98% in Normal Trading: Shares Decline Amidst Recent Developments - Stocks Telegraph
CASI Pharmaceuticals (NASDAQ: CASI) appoints James Huang Non-Executive Chairman - Stock Titan
Owner BioFortune Inc Files To Sell 500,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):